JP-listed companies
KISSEI PHARMACEUTICAL CO.,LTD.

KISSEI PHARMACEUTICAL CO.,LTD.JP:4547

Market cap

¥155.8B

P/E ratio

12.6x

Income statement Balance sheet Cash flow

	Mar 31, 2013	Mar 31, 2014	Mar 31, 2015	Mar 31, 2016	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023
Net sales	62,491	70,399	70,110	71,294	71,706	74,009	72,297	63,234	69,044	65,381	67,493
Cost of sales	21,146	23,182	24,063	23,582	25,076	25,878	26,735	28,340	36,322	34,143	35,118
Gross profit (loss)	41,345	47,217	46,047	47,711	46,630	48,131	45,562	34,893	32,723	31,238	32,374
Selling, general and administrative expenses	33,586	34,917	37,710	37,439	38,140	38,232	39,363	33,048	31,217	32,640	33,503
Operating profit (loss)	7,761	12,301	8,334	10,274	8,491	9,887	6,202	1,857	1,505	-1,402	-1,129
Interest income	68	78	83	71	46	33	35	57	30	42	23
Gain on sale of securities	-	-	-	-	-	-	-	-	-	-	50
Dividend income	629	780	809	919	916	1,048	1,077	1,170	1,242	1,544	1,379
Gain on sale of securities	-	-	-	-	-	-	-	-	-	-	50
Gain on valuation of securities	240	235	729	132	226	387	-	-	720	180	65
Gain on valuation of securities	240	235	729	132	226	387	-	-	720	180	65
Foreign exchange gains	-	-	485	-	-	-	-	-	-	-	186
Foreign exchange gains	-	-	485	-	-	-	-	-	-	-	186
Other	155	96	127	71	82	89	111	203	160	325	131
Other	155	96	127	71	82	89	111	203	160	325	131
Non-operating income	1,148	1,341	2,292	1,194	1,271	1,558	1,224	1,430	2,154	2,092	1,837
Non-operating income	1,148	1,341	2,292	1,194	1,271	1,558	1,224	1,430	2,154	2,092	1,837
Interest expenses	40	36	33	31	24	23	23	23	23	23	20
Foreign exchange losses	-	52	-	40	94	-	38	-	130	60	-
Provision of allowance for doubtful accounts	-	-	-	-	-	-	-	-	-	-	15
Other	20	6	8	3	5	8	18	32	29	44	73
Other	20	6	8	3	5	8	18	32	29	44	73
Non-operating expenses	60	102	42	115	124	32	257	859	183	127	109
Non-operating expenses	60	102	42	115	124	32	257	859	183	127	109
Ordinary profit (loss)	8,849	13,541	10,584	11,353	9,638	11,414	7,169	2,429	3,476	562	598
Gain on sale of non-current assets	-	46	11	1	18	-	1	27	-	-	67
Gain on sale of investment securities	-	-	7	-	652	320	3	2,236	4,084	16,601	13,018
Extraordinary income	-	46	18	1	670	320	4	2,264	4,087	16,601	13,086
Loss on sale of non-current assets	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of non-current assets	20	78	114	27	31	37	3	62	10	35	4
Loss on sale of investment securities	-	21	-	-	-	-	-	-	-	1	-
Loss on valuation of investment securities	836	-	-	-	-	-	-	-	77	619	-
Extraordinary losses	857	187	137	217	192	37	53	62	87	656	4
Profit (loss) before income taxes	7,992	13,400	10,466	11,136	10,116	11,697	7,121	4,630	7,476	16,507	13,680
Income taxes - current	3,127	4,510	3,407	2,969	2,291	3,223	1,634	390	1,510	4,017	2,113
Income taxes - deferred	-176	-226	-130	-28	59	-624	-47	1,351	587	-542	932
Income taxes	2,950	4,283	3,277	2,940	2,351	2,598	1,586	1,741	2,098	3,475	3,046
Profit (loss)	-	-	7,188	8,195	7,765	9,098	5,535	2,888	5,378	13,032	10,634
Profit (loss) attributable to non-controlling interests	-	-	23	30	39	52	54	71	93	110	105
Profit (loss) attributable to owners of parent	-	-	7,165	8,165	7,726	9,045	5,481	2,817	5,285	12,921	10,528